Clinical Breast Cancer

Title Publication Date Language Citations
The Importance of Naming Structural Racism as a Root Cause of Racial Inequities in Breast Cancer Outcomes2024/04/01English
Cyclin-Dependent Kinase 4/6 Inhibitors as Neoadjuvant Therapy of Hormone Receptor-Positive/HER2-Negative Early Breast Cancer: What do we Know so Far?2024/04/01English
The Impact of miRNAs on the Efficacy of Tamoxifen in Breast Cancer Treatment: A Systematic Review2024/01/01English
Inhibitory Impact Of Cinobufagin In Triple-Negative Breast Cancer Metastasis: Involvements Of Macrophage Reprogramming Through Upregulated MME and Inactivated FAK/STAT3 Signaling2024/01/01English
Can We Do Breast-Conserving Surgery Without Intraoperative Frozen Section of Margin?2024/04/01English
Elucidating Axillary Soft Tissue Involvement in Breast Cancer: Unveiling Metastatic Mechanisms and Therapeutic Perspectives2024/04/01English
Assessment of Oxygen Saturation in Breast Lesions Using Photoacoustic Imaging: Correlation With Benign and Malignant Disease2024/01/01English
Temporal Variation of Treatment Patterns and Survival Outcomes of Triple-Negative Breast Cancer Patients: A Real-World Experience From 2000 to 20142023/10/01English
Surgical Management of Breast Amyloidosis2023/08/01English
The Role of a Deep Learning-Based Computer-Aided Diagnosis System and Elastography in Reducing Unnecessary Breast Lesion Biopsies2023/04/01English
Breast Cancer With a HER2 FISH Group 2 Result: Should HER2 Tests be Repeated?2023/06/01English
Letter to the Editor of Clinical Breast Cancer, on “Time to Update Evidence-Based Guideline Recommendations About Concurrent Tamoxifen and Antidepressant Use? A Systematic Review,” Conducted by Michelle Bradbury and Collaborators and Published in Clinical Breast Cancer April Vol 22 no.4 e362-e373, 20222023/04/01English
Cost-effectiveness of Sacituzumab Govitecan versus Single-agent Chemotherapy for Patients with Metastatic Triple-Negative Breast Cancer in China2024/04/01English
Real-world data on pathological response and survival outcomes after neoadjuvant chemotherapy in HER2-low breast cancer patients2024/04/01English
Comparison of Performance in Diagnosis and Characterization of Breast Lesions: Contrast-Enhanced Mammography vs. Breast Magnetic Resonance Imaging2024/04/01English
De-escalation of Axillary Surgery After Neoadjuvant Therapy2024/04/01English
Locoregional management of multiple ipsilateral breast cancers: A review2024/04/01English
Biopsy or Follow-up: AI Improves the Clinical Strategy of US BI-RADS 4A Breast Nodules Using a Convolutional Neural Network2024/02/01English
Table of Contents2023/10/01English
Clinico-Pathological and Prognostic Significance of a Combination of Tumor Biomarkers in Iranian Patients With Breast Cancer2024/01/01English
Considerable Long-Term Aesthetic Outcomes and Oncologic Safety of Breast-Conserving Surgery Via a Periareolar Incision: A Retrospective Study2023/12/01English
Editorial Board2023/10/01English
Efficacy and Safety of Trastuzumab Deruxtecan in Breast Cancer: A Systematic Review and Meta-Analysis2023/12/01English
Editorial Board2023/08/01English
Table of Contents2023/08/01English
The Effects of High Deductible Health Plans on Breast Cancer Treatment and Reconstruction2023/12/01English
Bone-Targeted Therapy Regimen and Skeletal-Related Events in Patients Surviving Longer Than 2 Years With Metastatic Breast Cancer and Bone Metastasis2023/12/01English
Real-World Evidence on the Use of Endocrine Therapy for Ductal Carcinoma In Situ in Patients Treated With Breast-Conserving Surgery Followed by Postoperative Radiation Therapy: A Brazilian Retrospective Cohort Study2023/12/01English
A Population-Based Research Utilized a Risk Stratification Model to Forecast the Overall Survival of Young Women With Diagnosed Stage IV Breast Cancer2023/12/01English
Thromboembolism and Adjuvant Endocrine Therapy (AET) in Hormone Receptor-Positive Early Breast Cancer (EBC): Did Treatment Evolution Change Incidence of the Adverse Event? A Meta-Analysis2023/12/01English